Neurological Conditions

Orthostatic Hypotension

Orthostatic Hypotension ยท I95.1

Orthostatic hypotension is defined as a sustained reduction in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of at least 10 mmHg within 3 minutes of standing, causing dizziness, lightheadedness, and syncope.

2026-03-27

At a Glance

Orthostatic hypotension (OH) affects 5-30% of elderly adults. It is classified as neurogenic (autonomic failure) or non-neurogenic (volume depletion, medications). Neurogenic OH occurs in Parkinson's disease, MSA, pure autonomic failure, and diabetic neuropathy due to impaired sympathetic vasoconstriction. Tilt table testing and active standing test with beat-to-beat BP monitoring are diagnostic. Non-pharmacological measures include increased fluid (2-3L/day) and salt intake (6-10g/day), compression garments, and counterpressure maneuvers. Fludrocortisone and midodrine are first-line medications. Droxidopa is indicated for neurogenic OH.

Definition and Overview

Orthostatic hypotension (OH) is defined as a sustained reduction in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of at least 10 mmHg within 3 minutes of standing or during a head-up tilt to at least 60 degrees [1].

OH affects 5-30% of elderly adults and is classified as neurogenic (autonomic failure) or non-neurogenic (volume depletion, medications, cardiac). It is an independent risk factor for falls, cognitive decline, cardiovascular events, and mortality [2].

Causes

Neurogenic OH

Results from impaired sympathetic vasoconstriction due to autonomic nervous system degeneration:

  • Parkinson's disease (30-40% prevalence)
  • Multiple system atrophy (severe, early feature)
  • Pure autonomic failure
  • Diabetic autonomic neuropathy
  • Amyloid neuropathy

Non-neurogenic OH

  • Volume depletion: dehydration, hemorrhage, adrenal insufficiency
  • Medications: antihypertensives, diuretics, alpha-blockers, antidepressants, dopaminergic agents
  • Cardiac: aortic stenosis, heart failure, arrhythmias

Symptoms

Lightheadedness, dizziness, blurred vision, weakness, fatigue, presyncope, and syncope upon standing. Symptoms may worsen after meals (postprandial hypotension), prolonged standing, dehydration, and in hot environments [3].

Some patients develop "coat hanger" pain (suboccipital and shoulder pain from ischemia of neck muscles) as a characteristic symptom of neurogenic OH.

Diagnosis

Active standing test: measure BP and heart rate supine, then at 1 and 3 minutes of standing [1].

Head-up tilt table test: standardized, reproducible assessment. Beat-to-beat BP monitoring provides continuous data.

Neurogenic vs non-neurogenic differentiation: heart rate response is key. Neurogenic OH shows blunted heart rate increase (<15 bpm). HRV analysis, plasma norepinephrine levels (supine and standing), and QSART help characterize autonomic failure [4].

Treatment

Non-pharmacological

  • Increased fluid intake: 2-3 liters per day
  • Increased salt intake: 6-10 grams per day (unless contraindicated)
  • Compression garments: waist-high, 30-40 mmHg
  • Counter-pressure maneuvers: leg crossing, squatting
  • Head-of-bed elevation (10-15 degrees) to reduce supine hypertension
  • Small, frequent meals to reduce postprandial hypotension

Pharmacotherapy

Fludrocortisone (0.1-0.3 mg/day): mineralocorticoid that expands plasma volume [5].

Midodrine (2.5-10 mg TID): alpha-1 agonist that increases peripheral vascular resistance. Avoid dosing within 4 hours of bedtime.

Droxidopa: norepinephrine prodrug specifically approved for neurogenic OH.

Pyridostigmine: cholinesterase inhibitor that enhances ganglionic transmission without supine hypertension.

Frequently Asked Questions

FAQ content is being prepared.

References

  1. [1] Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG (2011). "Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome." Clinical Autonomic Research, 21: 69-72. DOI PubMed
  2. [2] Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lerner A, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017). "The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension." Journal of Neurology, 264: 1567-1582. DOI PubMed
  3. [3] Ricci F, De Caterina R, Fedorowski A (2015). "Orthostatic hypotension: epidemiology, prognosis, and treatment." Journal of the American College of Cardiology, 66: 848-860. DOI PubMed
  4. [4] Shibao C, Lipsitz LA, Biaggioni I (2013). "Evaluation and treatment of orthostatic hypotension." Journal of the American Society of Hypertension, 7: 317-324. DOI PubMed
  5. [5] Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2020). "Baroreflex dysfunction." New England Journal of Medicine, 382: 163-178. DOI PubMed
  6. [6] Low PA, Singer W (2008). "Management of neurogenic orthostatic hypotension: an update." Lancet Neurology, 7: 451-458. DOI PubMed
  7. [7] Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM (1993). "Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine." American Journal of Medicine, 95: 38-48. DOI PubMed
orthostatic hypotensionpostural hypotensiondizzinesssyncopetilt table testmidodrine

This content is provided for medical informational purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.